Innovation and imitation,opportunity and challenge
        
      
            Asia-Pacific Pharma IP Leader summit2019---14th-15th NOV, Beijing CHINAOn March 19, 2019, the World Intellectual Property Organization (WIPO) published its global intellectual property report 2018.Asian innovators filed more than half of their international patent applications through WIPO for the first time in 2018, with significant growth in China, India and South Korea, the report noted. As a technology-intensive industry, pharmaceutical industry attaches great importance to patent application and intellectual property protection.In recent years, the size of the global pharmaceutical market has maintained a steady growth, with China, South Korea, India and other emerging markets presenting a rapid growth momentum. Due to the different intellectual property policies of different countries, the strategic layout of global intellectual property, the differences of pharmaceutical intellectual property policies of Asia-pacific countries, the patent review process, litigation procedures and Generic drug patent strategy have gradually become the hot spots of the pharmaceutical intellectual property industry.In this context, the 2019 Asia-pacific Pharmaceutical IP Leader Summit will be held in Beijing on November 14-15, and will attract more than 500 industry experts from domestic and foreign pharmaceutical companies, biotechnology companies, governments, associations, law firms, intellectual property agents and other companies to attend.Agenda Framework:Section 1:Interpretation of Policy: Development of Pharmaceutical IP under the New Legislative Landscape Section 2:Pharmaceutical R&D Innovation and IP Protection -- Global VisionSection 3:Case Sharing of Pharmaceutical Patent Invalidity, Infringement, LitigationSection 4:Opportunities and challenges for generics companies under the new situation HOTSPOT:ü  Medical Policy Interpretation under the Background of Patent Law Amendmentü  The innovation of Judicial Mechanism Promotes the Development of Pharmaceutical Intellectual Propertyü  Intellectual Property Management Experience in Multinational Pharmaceutical Companies, Patent Layout Strategy, Litigation Strategyü  he Data Protection Regulations of Drug Test—New Eraü  Trade Secrets and Patent Layout in the Medical Fieldü  Establishing The Internal Intellectual Property System under The New Legislative Landscapeü  Opportunities and Challenges of Pharmaceutical Enterprises under Patent Term Compensation System--- Global Vision and Its Implications for Chinaü  Latest Changes in European Patent Application and Review Proceduresü  Analysis of Hot Cases of Recent Patent Invalidationü  The Procedure of American Pharmaceutical Patent litigation and its Enlightenment to Chinese Pharmaceutical Enterprises  ü  Application techniques and protection strategies for European and American biomedical patentsü  Changes in standards for creative review of patentsü  European, American and Japanese Medical Patent Examination Cases and its implications for DomesticPharmaceutical Companiesü  Recent Hot Patent Infringement Cases Analysisü  The Strategy of Indian Generic Drug Companies in R&D and Pre-PAü  How to avoid the Patent Trap in Generic Drug Developmentü  The Strategy of Generic Drug Companies to Enter the European and American Marketsü  Patentability in Europe, the United States and Chinaü  Patent litigation in Europeü  Doubts around the Unified Patent Court (UPC) agreement and Brexitü  Second medical use patentsComposition of participants:  Summit highlights:10+ Hot topic20+   Authoritative speech5 0+ Industry media4 0+ BIC110+pharma   company 500+專業參會嘉賓                  Professional participantsOfficial registration and consultation channels:Contact:AnnPhone: 021-65650305Email:Marketing@zenseegroup.comhttp://en.zenseegroup.com/p/510934/